Stopping smoking reduces risk of bacterial pneumonia in people with HIV

Bacterial pneumonia is one of the commonest and most serious infections occurring in people infected with HIV. A metanalysis of cohort and case control studies published in BioMed Central's open access journal BMC Medicine finds that current smokers with HIV were at double the risk of bacterial pneumonia than non-smoking counterparts, but that when people stopped smoking their risk was reduced.

The metanalysis reanalysed the data of several thousand participants with HIV, from 14 studies based in USA, Europe and South Africa. Overall it appeared that current smoking was associated with a 70-100% increase in risk of , compared to non-smokers, but that stopping smoking decreased this by about a third. This was independent of CD4 count or .

Prof Paul Aveyard, from University of Oxford who led the study explained that, "Antiretroviral treatment means that people with HIV can have a normal life expectancy. However they still have substantially increased health risks compared to the general population, including risk of pneumonia. Our results show that smokers with HIV have twice the risk of bacterial pneumonia, but that stopping smoking can reduce this risk. In order to prevent this potentially life threatening lung disease we believe that programs should be promoted as part of ."

More information: Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV Preeti De, Amanda Farley, Nicola Lindson and Paul Aveyard, BMC Medicine (in press)

add to favorites email to friend print save as pdf

Related Stories

Snuffing out smoking in those with HIV

Jun 03, 2010

While researchers have done a good job documenting health problems associated with the high prevalence of smoking among Americans who have HIV/AIDS, it's now time to focus on how to get these smokers to kick the habit, Saint ...

Recommended for you

Harm-reduction program optimizes HIV/AIDS prevention

Apr 21, 2014

(Medical Xpress)—New research from UC San Francisco and the San Francisco AIDS Foundation has found that clients participating in a harm-reduction substance use treatment program, the Stonewall Project, decrease their use ...

HIV+ women respond well to HPV vaccine

Apr 16, 2014

HIV-positive women respond well to a vaccine against the human papillomavirus (HPV), even when their immune system is struggling, according to newly published results of an international clinical trial. The study's findings ...

User comments